PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 259 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $351,903 | -70.1% | 12,300 | -69.5% | 0.01% | -78.1% |
| Q1 2024 | $1,176,660 | -11.3% | 40,269 | +2.5% | 0.03% | -27.3% |
| Q4 2023 | $1,325,982 | -26.6% | 39,300 | -33.2% | 0.04% | -36.2% |
| Q3 2023 | $1,806,223 | +285.3% | 58,873 | +403.2% | 0.07% | +283.3% |
| Q2 2023 | $468,819 | -65.7% | 11,700 | -66.9% | 0.02% | -75.0% |
| Q4 2022 | $1,366,099 | +251.2% | 35,382 | +447.5% | 0.07% | +200.0% |
| Q4 2021 | $389,000 | -74.0% | 6,463 | -73.8% | 0.02% | -83.4% |
| Q2 2021 | $1,498,000 | – | 24,685 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |